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Emma Cid, MD, K. Lance Gould, MD
Houston, Texas
O B J E C T I V E S We sought to quantify ranges of normal myocardial perfusion and ﬂow reserve in
young, asymptomatic volunteers after systematic historical and laboratory screening for unexpected
factors affecting coronary ﬂow.
B A C KG ROUND Noninvasive cardiac positron emission tomography (PET) quantiﬁes absolute ﬂow
and coronary ﬂow reserve (CFR), thereby deﬁning physiological severity of coronary artery disease for
clinical studies or management. Deﬁning “normal” coronary ﬂow is a necessary prerequisite to its broad
clinical application.
METHOD S Volunteers aged 20 to 40 years of age without cardiac disease or other conditions
underwent rest–dipyridamole stress cardiac PET with absolute quantitative ﬂow measurements using
Rb-82 in paired studies at least 7 days apart for reproducibility. The presence of coronary calcium,
detectable blood nicotine or caffeine, dyslipidemia, and an extended family history of early clinical
atherosclerosis were objectively and systematically examined for grouping subjects as true normal or not
normal.
R E S U L T S We enrolled 125 volunteers, 107 (86%) underwent 2 PET scans. Fifty-six (45%) were
classiﬁed as true normal, whereas 69 (55%) were classiﬁed as not normal. True normals had higher
high-density lipoprotein and less PET scan heterogeneity. Hemodynamic responses to dipyridamole
stress were similar. Rest ﬂow was the same in both groups (0.72  0.17 ml/min/g vs. 0.69  0.14
ml/min/g, p  0.164). However, stress ﬂow (2.89  0.50 ml/min/g vs. 2.63  0.61 ml/min/g, p  0.005)
and CFR (4.17  0.80 vs. 3.91  0.86, p  0.047) were higher in true normals. Paired studies were
performed a median of 22 days (interquartile range: 15 to 39) apart. Reproducibility was improved in the
true normal group.
CONC L U S I O N S One-half of young, asymptomatic volunteers from the community harbor unex-
pected factors that mildly but systematically reduce stress ﬂow, CFR, and reproducibility. This study
establishes normal ranges and reproducibility for ﬂow and CFR as the basis for clinical
applications. (J Am Coll Cardiol Img 2011;4:402–12) © 2011 by the American College of Cardiology
Foundation
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403sing coronary physiology to select patients
for revascularization is gaining importance,
as evidenced by the success of fractional flow
reserve in a large, randomized controlled trial
(1). The failure of misleading visual assessments of
natomic severity to improve outcomes is well docu-
ented (2–4). However, the invasiveness of fractional
ow reserve limits its application for broad popula-
ions. Noninvasive cardiac positron emission tomog-
aphy (PET) directly measures the absolute flow and
See page 413
flow reserve that fractional flow reserve indirectly
reflects, thereby expanding quantitative coronary
physiology for clinical studies and management (5).
Defining “normal” coronary flow is a necessary
prerequisite for its broad clinical application. How-
ever, coronary flow is dynamic, adapting to a wide
range of physiological conditions for ensuring ade-
quate myocardial perfusion. Autoregulation of blood
flow is affected by many intrinsic and extrinsic vari-
ables (6). Therefore, any study of normal flow must
reasonably account for factors that systematically alter
its quantification and reproducibility.
Young volunteers recruited for such a study may be
unaware of subclinical factors such as dyslipidemia or
coronary calcium. Additionally, paid research subjects
may hide known or suspected risk factors such as
nicotine use or family history that might otherwise
disqualify them. Therefore, we recruited and rigor-
ously screened by history and laboratory tests a large
cohort of young, healthy volunteers from the commu-
nity undergoing serial cardiac PET scans with quan-
titative flow measurements.
METHODS
All volunteers underwent rest–dipyridamole myo-
cardial perfusion PET with absolute flow quantifi-
cation between March 2008 and October 2010 at
the Weatherhead PET Center for Preventing and
Reversing Atherosclerosis of the University of
Texas Medical School at Houston and Memorial
Hermann Hospital after written informed consent
approved by the institutional review board.
Laboratory and study protocol. Volunteers aged 20
o 40 years and free from known cardiac disease,
isk factors, or any known medical condition were
ecruited from the community using approved ad-
ertisements. The majority of subjects underwent 2
ET scans separated by at least 7 days. A small einority of subjects dropped out of the study after
he first scan. At initial and follow-up visits, all
ubjects gave fasting serum and urine samples, and
lood pressure, body mass index, and a standard
2-lead electrocardiogram were recorded. All fe-
ale volunteers underwent a urine pregnancy test
n the day of each PET scan. Subjects were paid a
ominal, institutional review board–approved cash
tipend after each PET scan. Perfusion images and
aboratory findings were reviewed with each volun-
eer at completion of their studies with confirma-
ion or “remembered update” of medical and family
istory after the final payment.
PET acquisition and reconstruction protocol. Subjects
were instructed to fast for 4 h and abstain from
caffeine, theophylline, and cigarettes for 24 h.
Cardiac PET was performed using a Discovery ST
16-slice PET-CT multislice bismuth germanate
tomograph (GE Healthcare, Waukesha, Wiscon-
sin) in 2-dimensional mode with extended septa
and settings for an in-plane resolution of approxi-
mately 6 to 7 mm full-width at one-half–
maximum (7).
Subjects were positioned in the scanner
using laser guides aligned to the base of
the throat and confirmed by computed
tomography (CT) scout scan. External
body markers were used to ensure correct
positioning throughout data acquisition.
Rest emission images were obtained over 7
min beginning immediately upon intrave-
nous injection of 35 to 50 mCi (1,295 to
1,850 MBq) of generator-produced Rb-82
(Bracco Diagnostics, Princeton, New Jersey) and
contained 24 to 60 million total counts, of which 12
to 30 million were true coincidence counts. The
first 2 min of emission images were binned to form
arterial input data. The last 5 min of emission
images were binned to form myocardial uptake
data.
Immediately after completion of the resting scan,
dipyridamole (142 g/kg/min) was infused for 4 min.
our minutes after completion of dipyridamole infu-
ion, the same dose of radiotracer was given. Stress
mission images were acquired for 7 min and binned
nto arterial and myocardial images as for the resting
can. Dipyridamole-induced symptoms were treated
ith intravenous aminophylline. Hemodynamic pa-
ameters of heart rate and blood pressure were re-
orded at rest and during dipyridamole stress.
The CT scans for attenuation correction were
cquired before rest emission imaging and after stress
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404quisition have been previously reported (8,9). Images
ere reconstructed using filtered backprojection with
Butterworth filter (cutoff 0.55 cycles/cm; roll off 10
B/decade; pixel size 3.27  3.27 mm). Fusion
images superimposed PET emission and CT trans-
mission scans in horizontal, coronal, and sagittal
views. Coregistration was optimized by shifting as
needed (9,10). Estimated effective radiation dose from
the complete PET study (rest/stress Rb-82 and 2 CT
attenuation scans) is 7.47 mSv (8).
After attenuation correction and reconstruction, a
3-dimensional rotation algorithm on an Ultra 60
workstation (Sun Microsystems/Oracle, Santa Clara,
California) of an mPower-HZL PET scanner (Posi-
tron Corporation, Fishers, Indiana) running CAR-
DIAC version 4.66 software generated true short- and
long-axis views, perpendicular and parallel to the long
axis of the left ventricle (LV) from PET transaxial
images as previously described (8–15). Circumferen-
tial profiles of maximum radial activity for each true
short-axis slice were used to construct 2-dimensional
topographic views of the entire LV in lateral, inferior,
septal, and anterior quadrant views.
Absolute myocardial ﬂow. Peak integrated activity
ver an approximate 2 2-mm circular area in the left
trium or thoracic aorta was determined from trans-
xial images acquired during the first 2 min after each
adiotracer injection. Integrated myocardial activity
uring the next 5 min was determined from topo-
raphical maps of the LV. For each of 64 radial
egments at each of 21 short-axis slices, integrated
rterial input and integrated myocardial uptake were
sed to compute absolute myocardial flow using an
stablished model (16) implemented using custom
oftware. Partial volume corrections for aorta and
yocardium were based on quantitative phantom
tudies (17). The 21 64-pixel topographic flowmap
as smoothed using a 5 5-pixel average to suppress
oise introduced by the flow model. Coronary flow
eserve (CFR) was computed as the stress-to-rest ratio
n a pixel-by-pixel basis.
Figure 1 illustrates PET image orientation,
uantitative absolute and relative myocardial rubid-
um uptake (only single, representative quadrants
hown for publication efficiency), and different
ources of arterial input including the aortic root,
eft atrium, or just above the aortic root. The
ighest blood pool activity of these sources was used
s the arterial input while avoiding the subclavian
ein higher up next to the aorta. The CT scan
hows the anatomy but was not used in determining
he arterial input. Quantitative end points for relative uptake and abso-
lute ﬂow. Four basal slices were not used for quanti-
tative analysis due to low counts in the membranous
interventricular septum. Two apical slices were not
used for quantitative analysis due to potential partial
volume errors caused by partial thickness slices
through the LV apex and apical motion.
Combined size and severity of relative perfusion
defects were quantified by percentage of the whole
topographic image with relative activity less than
60% of maximum activity (100%) and the value in
the quadrant with the lowest average relative uptake
(minimum quadrant average). An established index
quantified resting and stress homogeneity (14).
Average absolute flow at rest and during dipyri-
damole hyperemia as well as CFR were computed
for each quadrant and the whole LV. Systolic blood
pressure and heart rate were recorded during rest
and stress imaging. Resting flow was analyzed as
measured and after normalizing by the pressure-rate
product (PRP) (flow divided by PRP then multi-
plied by 6,000 mm Hg·beats/min, equivalent to
standardized resting heart rate of 60 beats/min and
systolic pressure of 100 mm Hg) and stress flow at
PRP of 10,000 mm Hg·beats/min (equivalent to
standardized heart rate of 100 beats/min and sys-
tolic pressure of 100 mm Hg, as typically seen
during dipyridamole stress) to adjust for changes in
myocardial demand.
Volunteer categorization and factors affecting myocar-
dial perfusion. To screen for unknown and subclin-
cal factors, baseline serum and urine samples were
ested for lipid concentrations, serum caffeine level,
nd urine nicotine and its metabolite cotinine levels.
erum and urine samples at the second PET scan
ere similarly tested for caffeine and nicotine me-
abolites but not lipids. Electrocardiograms at each
isit were interpreted using standard criteria. De-
ailed personal and family medical history, focus-
ng on siblings, parents, and grandparents, given
he young age of the volunteers, was obtained at the
aseline visit and confirmed or expanded after the
nal cash payment to each subject.
Each volunteer was classified as either a true
ormal if no factors were abnormal or not normal
therwise. Abnormalities were classified as: coro-
ary calcium on attenuation CT scan (comparable
o dedicated calcium scoring [18]), detectable nic-
tine exposure (urine nicotine 10 ng/ml or coti-
ine 40 ng/ml), residual caffeine (serum level
1.0 mg/l), dyslipidemia (low-density lipoprotein
130 mg/dl, high-density lipoprotein [HDL] 40
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405mg/dl in males and 50 mg/dl in females, triglyc-
erides 150 mg/dl, non-HDL 160 mg/dl, or
occult anticholesterol medication use), extended
family history of early clinical atherosclerosis (myo-
cardial infarction, mechanical revascularization,
known coronary heart disease, or cerebral vascular
accident before age 55 years in men or 65 years in
women), or rare miscellaneous causes (clinical hy-
pertension with evidence of LV hypertrophy on
resting electrocardiogram, or a visual, moderately
severe perfusion defect on PET images).
Statistical methods. All statistical analyses were per-
ormed using R version 2.12 (19). Continuous
ariables are expressed as mean  SD, or median
interquartile range) for nonnormal distributions,
nd were compared using the Student t test (or
ilcoxon rank sum test for non-normal distribu-
Figure 1. Primary Cardiac PET Used to Measure Absolute Flow
Primary positron emission tomography (PET) imaging data: quan
quadrants are shown for publication efﬁciency) and arterial bloo
phy (CT) scans show anatomy but are not used in determining a
descending coronary artery; LCx  left circumﬂex coronary arter
nary artery; SVC  superior vena cava.ions), which were paired for serial studies in the came subject. For summary metrics for end points
hat contained a mixture of single and repeated
easures, the average of the repeated measures per
ubject was used to compute the mean. The SD for
hese summary metrics was computed using 1,000
andom sample distributions using 1 of the poten-
ially 2 repeated measures for each subject. Fre-
uency variables are expressed as number (percent-
ge) and compared using a chi-square or Fisher
xact test. Reproducibility for paired studies was
xamined by the Pearson correlation coefficient, the
eproducibility coefficient defined by 1.96 times the
D from the Bland-Altman plot expressed as a
ercentage of the average value, and the best-fit
lope by least squares. The coefficient of variation
as defined as the SD as a percentage of the mean.
ll applicable tests were 2-tailed, and p  0.05 was
ive myocardial rubidium uptake (only single, representative
ol activity from aorta or left atrium. The computed tomogra-
ial activity. Ao  aorta; LA  left atrium; LAD  left anterior
A  pulmonary artery; RA  right atrium; RCA  right coro-titat
d po
rter
y; Ponsidered statistically significant.
CAD  coronary artery d
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406RESULTS
We recruited 125 subjects of which 107 (86%)
underwent 2 PET scans. After examination for
unknown and subclinical factors, 56 (45%) were
classified as true normal whereas 69 (55%) were
classified as not normal. Table 1 gives the demo-
graphic, clinical, and relative PET uptake results.
True normals had higher HDL and less PET
scan heterogeneity, as reflected by the higher
minimum quadrant average and homogeneity
index at rest and stress. Hemodynamic responses
to dipyridamole stress were similar. Median-
detected caffeine level was 1.6 mg/l (interquartile
range: 1.4 to 2.3) and was 2 mg/l in 19 of 24
(63%) studies.
Figure 2 shows resting and stress quantitative
myocardial perfusion in ml/min/g and CFR (only
single, representative quadrants are shown for pub-
c, Clinical, and Relative Uptake PET Characteristics
ariable All Subjects
125
ies 107 (86%)
T 8 (6%)
its metabolites 8 (6%)
1.0 mg/l) 19 (15%)
38 (30%)
CAD 18 (14%)
4 (3%)
29 5
95 (76%)
2) 23.9 3.2
l) 166 36
92 27
55 14
74 (59–103)
111 36
pressure (mm Hg) 103 10
pressure (mm Hg) 59 7
ts/min) 61 9
roduct (mm Hg · beats/min) 6,279 1,261
ressure (mm Hg) 107 11
ressure (mm Hg) 60 8
s/min) 99 13
oduct (mm Hg · beats/min) 10,589 1,839
mum (%) 0.1 (0.0–0.8)
ximum (%) 0.0 (0.0–0.1)
nt average (%) 79 3
ant average (%) 82 3
x (no units) 0.49 0.10
dex (no units) 0.60 0.11
tomography (PET) perfusion defect (n  1) or electrocardiographic evidence of l
isease; CT  computed tomography; HDL  high-density lipoprotein; LDL  low-denlication efficiency). Resting perfusion is low since
this volunteer had a resting blood pressure of 99/62
mm Hg and heart rate of 48 beats/min, typical of
many healthy young subjects.
Resting flow was the same in true normals as not
normals. However, stress flow and associated CFR
were significantly higher in true normals, shown in
Table 2 and Figure 3. A moderate but significant
correlation existed between whole LV flow and
PRP in both true normals (r  0.67, p  0.001 for
rest; r 0.50, p 0.001 for stress) and not normals
(r  0.62, p  0.001 for rest; r  0.54, p  0.001
for stress). Whole heart flow was nonsignificantly
higher in females compared with males at rest (0.76 
0.15 ml/min/g vs. 0.69 0.15 ml/min/g) and stress
(2.83  0.47 ml/min/g vs. 2.72  0.61 ml/min/g),
which made CFR slightly lower in females (3.85 
0.59 vs. 4.08  0.90, p  0.049). The PRP did not
differ significantly between males and females.
rue Normals Not Normals p Value
56 (45%) 69 (55%)
48 (86%) 59 (86%) 1.00
0 (0%) 8 (12%)
0 (0%) 8 (12%)
0 (0%) 19 (28%)
0 (0%) 38 (55%)
0 (0%) 18 (26%)
0 (0%) 4 (6%)
28 5 29 5 0.93
44 (79%) 45 (65%) 0.12
22.6 2.5 25.0 3.3 1.00
161 26 170 42 0.93
89 23 95 30 0.90
59 12 52 15 0.003
68 (55–87) 83 (61–133) 0.47
102 24 118 42 1.00
100 9 105 11 1.00
57 6 61 7 1.00
62 10 60 9 0.08
6,232 1,268 6,320 1,256 0.65
104 9 109 12 0.99
58 7 61 8 1.00
101 13 97 14 0.06
0,569 1,792 10,603 1,885 0.54
0.1 (0.0–0.6) 0.2 (0.0–1.0) 0.55
0.0 (0.0–0.0) 0.0 (0.0–0.2) 0.51
80 3 79 3 0.011
83 3 81 3 0.005
0.52 0.10 0.46 0.09 0.001
0.64 0.10 0.57 0.10 0.001
ntricular (LV) hypertrophy and history of hypertension (n  3).Table 1. Demographi
V T
Number of subjects
Number of paired stud
Coronary calcium on C
Detectable nicotine or
Detectable caffeine (
Dyslipidemia
Family history of early
Miscellaneous*
Age (years)
Male sex
Body mass index (kg/m
Total cholesterol (mg/d
LDL (mg/dl)
HDL (mg/dl)
Triglycerides (mg/dl)
Non-HDL (mg/dl)
Resting systolic blood
Resting diastolic blood
Resting heart rate (bea
Resting pressure-rate p
Stress systolic blood p
Stress diastolic blood p
Stress heart rate (beat
Stress pressure-rate pr 1
Rest % LV 60% maxi
Stress % LV 60% ma
Rest minimum quadra
Stress minimum quadr
Rest homogeneity inde
Stress homogeneity in
*Visual positron emission eft ve
sity lipoprotein.
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407Paired studies were performed a median of 22 days
(interquartile range: 15 to 39 days) apart. No differ-
ence in stress PRP was noted between studies. How-
ever, rest PRP was lower on the second study in true
normals (6,504  1,377 vs. 5,914  1,112, p 
.024) but not significantly different in the not nor-
als. As detailed in Table 3, resting flow in true
ormals was lower on the second study, but paired
tress flows and CFR were not statistically different.
or subjects with unknown factors, paired rest flows
nd CFR were not different between scans, but stress
ow was significantly lower on the second study.
Figure 2. Example Flow and CFR in a True Normal Volunteer
Resting and stress quantitative myocardial perfusion in ml/min/g and c
pressure of 99/62 mm Hg and heart rate of 48 beats/min. Only single,
Table 2. Absolute Flow and CFR in True Normals and Not Norm
All Subjects
Rest conditions (ml/min/g)
Whole 0.70 0.15
Anterior 0.70 0.16
Septal 0.70 0.15
Lateral 0.70 0.16
Inferior 0.66 0.14
Stress conditions (ml/min/g)
Whole 2.75 0.58
Anterior 2.76 0.61
Septal 2.74 0.58
Lateral 2.74 0.58
Inferior 2.58 0.56
Coronary ﬂow reserve
Whole 4.03 0.84
Anterior 4.04 0.89
Septal 4.02 0.85
Lateral 4.03 0.89
Inferior 4.05 0.86CFR  coronary ﬂow reserve.orrelation and reproducibility coefficients were uni-
ormly higher in the true normal group, as shown in
igure 4.
Adjusting resting flow for PRP removed differ-
nces between scans for true normal subjects (whole
V 0.69  0.10 ml/min/g vs. 0.71  0.11 ml/
in/g at 6,000 PRP, p  0.248) and had mixed
ffects on measures of reproducibility (Pearson r 
.43, slope  1.02  0.02, reproducibility coeffi-
ient  32%). Adjusting stress flow for PRP atten-
uated but did not normalize differences between not
normal subjects (whole LV 2.60  0.54 ml/min/g
nary ﬂow reserve (CFR) in a healthy volunteer with a resting blood
esentative quadrants are shown for publication efﬁciency.
True Normals Not Normals p Value
0.72 0.17 0.69 0.14 0.16
0.73 0.18 0.69 0.15 0.09
0.71 0.17 0.69 0.14 0.21
0.72 0.17 0.69 0.15 0.17
0.67 0.15 0.64 0.13 0.09
2.89 0.50 2.63 0.61 0.005
2.92 0.53 2.62 0.65 0.003
2.88 0.51 2.63 0.61 0.006
2.87 0.50 2.64 0.62 0.012
2.74 0.48 2.46 0.60 0.002
4.17 0.80 3.91 0.86 0.047
4.18 0.83 3.94 0.92 0.06
4.17 0.82 3.89 0.85 0.033
4.14 0.82 3.94 0.93 0.10
4.20 0.79 3.93 0.89 0.038oroals
i
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408vs. 2.44  0.47 ml/min/g at 10,000 PRP, p 
0.028), and did not improve measures of reproduc-
ibility (Pearson r  0.40, slope  0.91  0.03,
reproducibility coefficient  43%).
Rest
p = 0.164
Stress
p = 0.005
CFR
p = 0.047
All patients (N = 125)
True normals (N = 56)
Not normals (N = 69)
Bar Graph of Flow and CFR by Normal Group
tress myocardial perfusion (ml/min/g) and coronary ﬂow reserve
nits) for all subjects (blue, n  125), true normals (green, n  60),
rmals (pink, n  65). Rest ﬂow was not different between normal
t stress ﬂow and CFR were signiﬁcantly higher for true normals.
represent 1 SD.
ity of Paired Studies
True Normals (48 Paired Studies)
First
Study
Second
Study Difference r Slope
n/g)
0.74 0.16 0.69 0.15 0.05 0.13* 0.68 0.92 0.02
0.75 0.17 0.69 0.15 0.05 0.14* 0.64 0.91 0.02
0.73 0.17 0.69 0.15 0.04 0.12* 0.72 0.93 0.02
0.75 0.18 0.69 0.14 0.06 0.15* 0.59 0.90 0.03
0.69 0.16 0.65 0.14 0.04 0.12* 0.68 0.93 0.02
in/g)
2.90 0.50 2.89 0.53 0.01 0.50 0.53 0.98 0.02
2.93 0.52 2.92 0.54 0.01 0.54 0.49 0.98 0.03
2.89 0.49 2.89 0.55 0.01 0.48 0.57 0.99 0.02
2.91 0.53 2.86 0.50 0.05 0.52 0.48 0.97 0.03
2.76 0.51 2.74 0.46 0.02 0.53 0.41 0.97 0.03
4.09 0.84 4.30 0.70 0.22 0.81 0.47 1.03 0.03
4.09 0.84 4.33 0.74 0.24 0.85 0.43 1.03 0.03
4.08 0.86 4.30 0.74 0.21 0.79 0.52 1.03 0.03
4.09 0.92 4.28 0.70 0.19 0.91 0.39 1.01 0.03
4.13 0.85 4.32 0.71 0.19 0.82 0.45 1.02 0.03
ent t test between studies.
erve; r  Pearson correlation coefﬁcient; RC  reproducibility coefﬁcient from Bland-ADI SCUSS ION
We demonstrate that unsuspected factors that are
present in one-half of young, asymptomatic volun-
teers from the community reduce stress flow and
CFR. Our large cohort of volunteers defines the
normal CFR range as 4.17  0.80, whereas the
presence of 1 or more abnormalities reduces this
level significantly to 3.91  0.86. True normal
stress flows during dipyridamole increase to 2.89 
0.50 ml/min/g, compared with 2.63 0.61 ml/min/g
n volunteers with 1 or more abnormalities. Repro-
ucibility is reduced in subjects with occult or subclin-
cal factors. Since asymptomatic, diffuse, nonobstruc-
ive coronary atherosclerosis is common in middle-
ged or older people, we selected young volunteers in
rder to define the range of true normal human
yocardial perfusion and CFR as physiological guides
n clinical studies or management.
Coronary flow by PET is a sensitive, distin-
uishing marker even in populations whose age,
lood pressure, and lipids suggest low homoge-
eous risk. Given the intergenerational age gap of
0 to 30 years in our cohort, with an average age
f 27, their parents and siblings might still
evelop early coronary heart disease, which ren-
ers a “negative” traditional family history at the
Not Normals (59 Paired Studies)
First
Study
Second
Study Difference r Slope RC
0.71 0.15 0.69 0.14 0.01 0.12 0.62 0.96 0.02 35%
0.70 0.15 0.69 0.15 0.01 0.14 0.57 0.96 0.02 39%
0.71 0.15 0.70 0.13 0.01 0.12 0.66 0.97 0.02 33%
0.71 0.14 0.69 0.16 0.02 0.15 0.53 0.95 0.03 41%
0.65 0.14 0.64 0.12 0.02 0.11 0.61 0.96 0.02 34%
2.72 0.63 2.55 0.60 0.18 0.55* 0.61 0.92 0.02 41%
2.71 0.68 2.55 0.65 0.17 0.61* 0.58 0.92 0.03 45%
2.71 0.63 2.55 0.59 0.17 0.52* 0.64 0.92 0.02 39%
2.75 0.64 2.55 0.62 0.20 0.59* 0.55 0.91 0.03 44%
2.54 0.61 2.37 0.58 0.17 0.54* 0.6 0.91 0.03 43%
3.97 0.91 3.77 0.83 0.20 1.00 0.34 0.92 0.03 51%
3.97 0.91 3.78 0.90 0.19 1.07 0.30 0.92 0.03 54%
3.95 0.91 3.73 0.78 0.22 0.95 0.39 0.91 0.03 48%
3.99 0.95 3.84 0.93 0.16 1.13 0.28 0.92 0.03 56%
3.99 0.96 3.78 0.85 0.21 1.05 0.33 0.91 0.03 53%0
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and not no
groups, buTable 3. Reproducibil
Sector RC
Rest conditions (ml/mi
Whole 35%
Anterior 37%
Septal 33%
Lateral 41%
Inferior 36%
Stress conditions (ml/m
Whole 34%
Anterior 36%
Septal 33%
Lateral 36%
Inferior 38%
Coronary ﬂow reserve
Whole 38%
Anterior 39%
Septal 37%
Lateral 43%
Inferior 38%
*p  0.05 for paired Stud
ltman analysis.
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409time of our PET study less meaningful. There-
fore, family history needs to consider a second
generation old enough for manifest, accelerated
atherosclerosis in grandparents, thereby extend-
ing our prior demonstration of early relative PET
perfusion abnormalities in offspring of patients
with clinical disease (15).
Volunteers are self-selected by definition. Some
subjects may have a strong family history, desire
“free” screening, and are therefore more likely to
have abnormalities despite initial “negative” family
history. Other subjects may have already focused on
a healthy lifestyle and are therefore healthier than
their peers. Bias due to subject recall, lack of
knowledge, preconceived expectation, or financial
need can taint admitted risk factors. Therefore, a
volunteer can be classified as a true normal only
after objective systematic search for occult and
subclinical factors altering coronary flow. To our
knowledge, no other study has quantified coronary
flow after accounting for these potential biases.
The differences between true normal subjects and
those with unexpected abnormalities demonstrate
Figure 4. Scatter Plots of Paired Flow Studies
Paired myocardial perfusion (in ml/min/g) and coronary ﬂow reserv
mals (n  59 pairs), where rest  blue, stress  red, CFR  green
lation coefﬁcients are higher for true normals, whose stress ﬂow ansubtle but detectable differences in cardiovascular pphysiology. For example, the significantly lower
resting PRP at the second visit seen only in true
normals suggests less sympathetic drive or an adap-
tive familiarity with the PET scanner, dipyridamole
side effects, research protocol, and confidence in
meeting study criteria. The absence of a similar
adaptive change between scans in not normals
might be due to caffeine or nicotine exposure,
anxiety over unknown history, or concealment of
occult history or medications that might exclude
them from the study. The lower stress flow and
reduced reproducibility in not normals compared to
true normals suggests that interscan variation is
enhanced by factors such as caffeine, nicotine,
dyslipidemia, history anxiety, or potential subclini-
cal atherosclerosis.
Comparison to existing literature. Table 4 summa-
izes absolute flow quantification by PET in 421
ormal volunteers undergoing vasodilator stress
n 29 studies over 20 years. Average cohort size
as 15 patients, with the largest study including
nly 61 patients, less than one-half the size of our
tudy. Our flows are somewhat lower than re-
FR) (no units) for (A) true normals (n  48 pairs) and (B) not nor-
black dashed line represents perfect agreement. Pearson corre-
R are signiﬁcantly higher.e (C
. Theorted in the literature, whereas CFR is compa-
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410rable, in part due to careful screening for “true
normal” and systematically selecting the higher
arterial activity from the aorta or left atrium. The
coefficient of variation is approximately 20% and
consistent throughout the literature. The varia-
tions in flow could be due to sample size, radio-
tracers, flow models, arterial input location, PET
scanners, attenuation correction, attention to
technical details and techniques, or unexpected
factors not sought systematically by any other
study. Table 5 summarizes 11 studies that exam-
ned reproducibility of absolute flow by cardiac
ET. Some studies rescanned patients almost
mmediately, whereas others waited at least 24 h.
mmary of Normal Flow and CFR by Cardiac PET
Citation Radiotracer n Rest Flow Res
992;20:979 N-13 20 1.100.20 1
tion 1993;88:62 N-13 18 0.76 0.17 2
tion 1994;90:808 N-13 11 0.66 0.09 1
95;2:413 N-13 6 0.68 0.12 1
995;26:1465 N-13 5 0.62 0.09 1
995;36:575 N-13 11
995;36:581 N-13 19 0.96 0.02
996;28:757 N-13 10 0.74 0.15 2
96;3:494 N-13 8 0.70 0.14 2
996;37:1626 N-13 30 0.64 0.15 2
996;37:1937 N-13 14 0.70 0.17 2
997;38:442 N-13 10 0.61 0.09 1
97;80:27 N-13 10 0.68 0.16 2
998;31:534 N-13 20 0.67 0.11 1
tion 1996;93:2000 N-13, O-15 15 0.65 0.11 1
tion 1988;78:104 O-15 4 0.97 0.07
991;32:2037 O-15 11 1.16 0.32 2
tion 1991;83:875 O-15 11 0.84 0.09 1
tion 1992;86:167 O-15 8 0.95 0.13 1
1994;330:1782 O-15 21 1.13 0.26 2
998;32:147 O-15 19 0.81 0.21 2
000;36:103 O-15 61 0.87 0.14 1
tion 2002;105:2878 O-15 12 0.79 0.18 2
03;10:275 O-15 11 0.96 0.19 2
003;44:146 O-15 11 1.24 0.19 1
tion 1993;87:173 O-15, Cu-62 5 1.01 0.32 3
009;50:68 Rb-82 15 0.80 0.25 3
I 2007;34:1765 Rb-82, N-13 14 0.69 0.12 1
001;42:201 Rb-82, O-15 11 1.04 0.33 3
all Various 421 0.84 0.16 1
Rb Rb-82 40 0.81 0.24 3
Rb-82 125 0.70 0.15* 2
weighted average for all isotopes and for Rb-82; **p  0.05 compared with wei
n (SD as percentage of mean); AJC American Journal of Cardiology; EJNMMI Europea
of Nuclear Cardiology; JNM  Journal of Nuclear Medicine; NEJM  New England Journalll had much smaller sample sizes than our current cohort. However, Pearson correlation and
eproducibility coefficients are similar to our
tudy. Reproducibility of invasive CFR has been
xamined in smaller numbers of studies, but
ever in young, asymptomatic volunteers. How-
ver, 1 study of 15 patients undergoing immedi-
te restudy during invasive angiography showed a
earson r  0.77 with a 19% coefficient of
ariation (20), similar to the values for our
ohort. Other investigators have observed a re-
uction in flow due specifically to caffeine (21),
icotine (22), and risk factors such as hyperten-
ion (23). Detectable caffeine in 15% of volun-
eers compares with rates near 20% after 24 h in
V Stress Flow Stress COV CFR CFR COV
4.35 1.10 25% 4.15 1.45 35%
3.00 0.76 25% 4.08 0.90 22%
2.65 0.39 15% 4.28 0.53 12%
2.41 0.61 25% 3.61 0.93 26%
2.51 0.27 11% 4.10 0.71 17%
2.13 0.28 13%
3.40 0.57 17% 4.60 0.90 20%
2.48 0.78 31% 3.67 1.33 36%
2.02 0.35 17%
2.86 1.20 42% 4.13 1.38 33%
1.86 0.27 15% 3.16 0.80 25%
2.04 0.30 15% 3.16 0.85 27%
2.86 0.49 17% 4.29 0.66 15%
2.68 0.76 28%
4.25 1.54 36% 3.90 1.50 38%
3.52 1.12 32% 4.19 1.25 30%
3.37 1.25 37% 3.16 1.40 44%
3.80 1.44 38% 4.99 2.50 50%
3.63 1.02 28% 4.23 1.29 30%
3.83 1.02 27% 4.95 1.32 27%
3.63 1.23 34% 3.86 1.24 32%
5.05 0.90 18% 4.14 0.84 20%
3.37 1.09 32% 4.38 1.52 35%
2.77 0.66 24% 4.13 1.14 28%
2.20 0.52 24%
3.16 0.85 27% 4.11 1.23 30%
2.85 0.84 30% 4.32 1.45 33%
2.74 0.58** 21% 4.03 0.85 21%
d average for all isotopes only.
rnal of Nuclear Medicine and Molecular Imaging; JACC Journal of the American College
edicine; other abbreviations as in Tables 1 and 2.Table 4. Literature Su
Author t CO
Chan JACC 1 8%
Czernin Circula 2%
Dayanikli Circula 3%
Sawada JNC 19 8%
Beanlands JACC 1 5%
Czernin JNM 1
de Jong JNM 1 2%
Muzik JACC 1 0%
DeGrado JNC 19 0%
Nagamachi JNM 1 3%
Yokoyama JNM 1 4%
Böttcher JNM 1 5%
Campisi AJC 19 4%
Muzik JACC 1 6%
Nitzsche Circula 6%
Iida Circula 7%
Senneff JNM 1 8%
Araujo Circula 1%
Yamamoto Circula 4%
Uren NEJM 3%
Laine JACC 1 6%
Kaufmann JACC 2 6%
Furuyama Circula 3%
Yoshinaga JNC 20 0%
Wyss JNM 2 5%
Herrero Circula 2%
Manabe JNM 2 1%
Lortie EJNMM 7%
Lin JNM 2 1%
Weighted average for 9%
Weighted average for 0%
Current study 1%
*p  0.05 compared with ghte
COV coefﬁcient of variatio n Jou
of Cardiology; JNC  Journal of Mlinical patients (24).
W
A
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411Study limitations. Variation and reproducibility in
our data arise from 2 sources. First, biological
variability among subjects and over the short time
between scans represents physiological changes ex-
emplified by significant adaptive decrease in PRP in
the true normals of this study. Second, variability
due to methodology arises from the radioactive
tracer, PET scanner hardware, reconstruction algo-
rithms, and flow model (25–28), but there is no
independent gold standard for comparing PET-
determined myocardial perfusion in humans to
assess methodological accuracy. However, our flow
method has been validated in an animal model (16),
our technical imaging details extensively published
(8–15), and every quantitative perfusion measure-
ment at every step was made by 2 experienced,
unbiased technicians and confirmed personally in
every detail at every step for every study by the
senior author.
Intravenous dipyridamole is a widely used tech-
Table 5. Literature Summary of Reproducibility of Flow by Card
Author Citation Radiotracer n
Chan JACC 1992;20:979 N-13 20
Herrero Circulation 1993;87:173 Cu-62, O-15 5
Nitzsche Circulation 1996;93:2000 O-15, N-13 15
Kaufmann JNM 1999;40:1848 O-15 21
Lin JNM 2001;42:201 O-15, Rb-82 11
Wyss JNM 2003;44:146 O-15 11
Manabe JNM 2009;50:68 Rb-82 15
Sawada JNC 1995;2:413 N-13 6
Czernin JNM 1995;36:575 N-13 11
Nagamachi JNM 1996;37:1626 N-13 30
Lortie EJNMMI 2007;34:1765 N-13, Rb-82 14
Current study (true normals) Rb-82 52
Current study (not normals) Rb-82 55
NS  not signiﬁcant (p value not explicitly reported in publication); r  Pearso
Tables 1, 2, and 4.Optimal medical therapy with or with- Rev Cardiol 2010;7doses, it may not produce maximal hyperemia in
every subject (29). Step-wise dose increases or
intracoronary papaverine to ensure maximal flow
are not feasible during cardiac PET.
CONCLUS IONS
One-half of young, asymptomatic volunteers drawn
from the community harbor unexpected factors that
mildly but systematically reduce stress flow and
CFR. After appropriate screening as in this study,
cardiac PET now has established normal ranges and
reproducibility data for quantitative perfusion and
CFR from a large cohort as the basis for clinical
applications.
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PET
Rest Stress
aration t-Test r RC t-Test r RC t-
ediate NS
ediate NS 0.87
ediate 0.33 0.99 33% 0.16 0.97 13%
ediate NS 18% NS 25%
ediate 0.66 0.28
ediate NS 0.77 21% NS 0.76 27%
ediate 0.31 0.93 24% 0.81 0.94 27% 0
ayed 0.31 0.24 28% 0.29 27% 0
ayed NS
ayed NS 0.63 30% NS 0.69 18%
ayed 0.13 0.11 0
ayed 0.01 0.68 35% 0.87 0.53 34% 0
ayed 0.38 0.62 35% 0.017 0.61 41% 0
rrelation coefﬁcient; RC  reproducibility coefﬁcient from Bland-Altman analysis;nique to induce hyperemia. However, at standard ton, Texas 77030. E-mail: K.Lance.Gould@uth.tmc.edu.R E F E R E N C E S
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